Cargando…
Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database Analysis
Hyperuricemia has been associated with chronic kidney disease (CKD) progression. The antihyperuricemic febuxostat's potential renoprotective effect has been demonstrated in stage 1–3 CKD. Large‐scale studies comparing the renoprotective potential of febuxostat and allopurinol in advanced CKD ar...
Autores principales: | Hsu, Yun‐Shiuan O., Wu, I‐Wen, Chang, Shang‐Hung, Lee, Cheng‐Chia, Tsai, Chung‐Ying, Lin, Chan‐Yu, Lin, Wan‐Ting, Huang, Yu‐Tung, Wu, Chao‐Yi, Kuo, George, Hsiao, Chih‐Yen, Lin, Hsing‐Lin, Yang, Chih‐Chao, Yen, Tzung‐Hai, Chen, Yung‐Chang, Hung, Cheng‐Chieh, Tian, Ya‐Chong, Kuo, Chang‐Fu, Yang, Chih‐Wei, Anderson, Gerard F., Yang, Huang‐Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232862/ https://www.ncbi.nlm.nih.gov/pubmed/31628864 http://dx.doi.org/10.1002/cpt.1697 |
Ejemplares similares
-
The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol
por: Ryu, Dong-Ryeol
Publicado: (2017) -
Risk Factors for Development of Septic Shock in Patients with Urinary Tract Infection
por: Hsiao, Chih-Yen, et al.
Publicado: (2015) -
Sex difference in heart failure risk associated with febuxostat and allopurinol in gout patients
por: Cheng, Ching-Lan, et al.
Publicado: (2022) -
Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
por: Kim, Sollip, et al.
Publicado: (2017) -
Predialysis hypotension is not a predictor for mortality in long-term hemodialysis patients: insight from a single-center observational study
por: Huang, Wen-Hung, et al.
Publicado: (2016)